Communiqués Nipro Corporation

Actions

8086

JP3673600007

Equipement, fournitures et distribution médicale

Marché Fermé - Japan Exchange Autres places de cotation 08:30:00 12/06/2026			Varia. 5j.	Varia. 1 janv.
1 688,50 ^JPY	-1,97%		-3,49%	+14,32%

12/05	Nipro Corporation communique ses prévisions de résultats consolidés pour le premier semestre 2026 et l'exercice clos au 31 mars 2027	CI
12/05	Nipro Corporation annonce le dividende final de l'exercice clos le 31 mars 2026, payable le 10 juin 2026 ; communique ses prévisions de dividende semestriel et annuel pour l'exercice s'achevant le 31 mars 2027	CI

Communiqués

25/03	Nipro : Announcement of Investment by Development Bank of Japan Inc. in a U.S. Subsidiary of NIPRO	PU
24/03	Nipro : Notice Concerning Change in Depreciation Method	PU
18/03	Nipro : Announcement of Spryte Medical, a US Affiliate of NIPRO, First Participants Enrolled in the “INSYTE” US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment	PU
11/03	Nipro : Notice Concerning the Establishment of the Record Date for the Year-End Dividend	PU
26/02	Nipro : Announcement of Expansion of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE HealthCare	PU
25/02	Nipro : Notice Regarding the Establishment of the Nomination and Compensation Committee	PU
04/02	Nipro : Announcement of Avantec Vascular, a US Affiliate of NIPRO, Receives FDA 510(k) clearance of DVT-Focused Thrombectomy System	PU
15/12	Nipro : Notice of Subsidiary Name Change and Transfer of Sales Organization of Vascular Division	PU
08/12	Nipro : Investment Agreement with the GHIT Fund on the development of a new detection kit for Mpox	PU
20/11	Nipro : Announcement of Spryte Medical, a US Affiliate of NIPRO, Receives FDA IDE Approval to Initiate "INSYTE" US Pivotal Trial evaluating the nOCT Imaging System during Brain Aneurysm Treatment	PU
28/10/25	Nipro : Notice Concerning Acquisition of Shares of G2/Spryte Holdco, LLC (to Make It a Subsidiary)	PU
29/08/25	NIPRO : Strengthens Americas Presence with Trade Name Change to Nipro Americas Group	PU
08/08/25	Nipro : Announcement of Commercial Collaboration Between Gentuity LLC, a US Affiliate of NIPRO, and GE Healthcare	PU
27/06/25	Nipro : Notice of Organizational and Personnel Changes	PU
26/06/25	Nipro : Announcement of Executive Personnel Changes	PU
09/06/25	Samsung Bioepis Enters into a Strategic Partnership with NIPRO for Commercialization of Multiple Biosimilars in Japan	AQ
22/05/25	Nipro : Notice of Personnel Change	PU
18/04/25	Nipro : Notice of Personnel Changes	PU
17/04/25	Nipro : Notice of Trade Name Change of Medical Device Subsidiary in the Republic of Korea	PU
23/01/25	Nipro : Notice of International Sales Launch of DIAMAX™ WOW Single Patient Dialysis Machines	PU
17/01/25	Nipro : Notice of Trade Name Change of Medical Device Subsidiary in the USA	PU
19/07/24	Nipro : Notice Regarding Acquisition of Plant Site for Manufacturing Medical Devices in the USA	PU
05/01/23	Nipro : New Year's Message from Sano Yoshihiko, President of NIPRO CORPORATION (January 5, 2023)	PU
22/12/22	Nipro : Notice of Establishment of Liaison Office in Nepal	PU
31/08/22	Nipro : Notice of Trade Name Change of Canadian Medical Device Sales Subsidiary	PU